CD8A and neoplasm: observed that patients with metastatic CRC involving poor responses to immunotherapy had higher levels of F. nucleatum and succinic acid, suggesting a mechanism that F. nucleatum–derived succinate inhibits the cGAS-interferon-β pathway, thereby suppressing the antitumor response by limiting the in vivo CD8+ T-cell transport to the tumor microenvironment (TME).